✦ LIBER ✦

Efficacy of interferon α-2b and lamivudine combination treatment in comparison to interferon α-2b alone in chronic delta hepatitis: A randomized trial

✍ Scribed by Billur Canbakan; Hakan Senturk; Fehmi Tabak; Meral Akdogan; Veysel Tahan; Ali Mert; Necdet Sut; Resat Ozaras; Kenan Midilli; Gulsen Ozbay

Book ID: 108950641
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 93 KB
Volume: 21
Category: Article
ISSN: 0815-9319
DOI: 10.1111/j.1440-1746.2006.04082.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of hepatitis B vaccination and

Efficacy of hepatitis B vaccination and interferon-α-2b combination therapy versus interferon-α-2b monotherapy in children with chronic hepatitis B

✍ MEHMET HELVACI; ASLI KIZILGUNESLER; ERHUN KASIRGA; EBRU OZBAL; MUGE KUZU; GULBEN 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

A randomized controlled trial of amantad

A randomized controlled trial of amantadine plus interferon-α2a vs. interferon-α2a alone in naive patients with chronic hepatitis C randomized according to the early virological response to interferon-α2a monotherapy

✍ M. Angelico; M. Cepparulo; F. Angelico; S. Francioso; A. Barlattani; F. Di Candi 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

Interferon α-2b with and without ribavir

Interferon α-2b with and without ribavirin in the treatment of hepatitis B e antigen–positive chronic hepatitis B: A randomized study

✍ Chun-Jen Liu; Ming-Yang Lai; You-Chen Chao; Li-Ying Liao; Sien-Sing Yang; Tun-Je 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB 👁 1 views

To study whether interferon (IFN) ␣ and ribavirin combination therapy has a beneficial effect for hepatitis B e antigen (HBeAg)-positive chronic hepatitis B, we enrolled 119 such patients in a randomized study. Fifty-nine patients received 5 million units of IFN-␣2b daily for 4 weeks followed by 5 m

Randomized trial comparing pegylated int

Randomized trial comparing pegylated interferon α-2b versus pegylated interferon α-2a, both plus ribavirin, to treat chronic hepatitis C in human immunodeficiency virus patients

✍ Montserrat Laguno; Carmen Cifuentes; Javier Murillas; Sergio Veloso; Maria Larro 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 370 KB

A randomized controlled trial of pegylat

A randomized controlled trial of pegylated interferon α-2a (40 KD) or interferon α-2a plus ribavirin and amantadine vs interferon α-2a and ribavirin in treatment-naïve patients with chronic hepatitis C

✍ A. Mangia; G. L. Ricci; M. Persico; N. Minerva; V. Carretta; D. Bacca; M. Cela; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB

A randomized controlled trial of lymphob

A randomized controlled trial of lymphoblastoid interferon-α in patients with chronic hepatitis B lacking HBeAg

✍ Giovanna Fattovich; Patrizia Farci; Massimo Rugge; Lucio Brollo; Antonella Manda 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 641 KB

Ongoing hepatitis B virus replication in the presence of antibody to HBeAg can be observed in patients with active liver disease. These forms of chronic hepatitis B have been described as having a poor prognosis. We have conducted a randomized controlled trial to assess the efficacy of lymphoblastoi